Skip to main content
. 2019 Oct 26;3:64. doi: 10.1186/s41687-019-0153-y

Table 2.

Summary of Responsiveness Results

Parameter Threshold for Acceptability Analysis Population Average Daily BMs
Overall Change from Baseline Change from Baseline at Week 12
N SES N SES
Responsiveness (SES)
Adequate relief (changed to Yes at Week 12)a

Standard Effect Size:

-Small (≥ 0.2)

-Moderate (≥ 0.5)

-Large (≥ 0.8)

ITT 19 −0.99 18 −1.40
Perception of change in BMsb
A great deal better ISP 9 −1.44 8 −1.80
Much better ISP 4 −0.50 4 −0.60
Satisfaction with study medication—Relief of CSc
Very satisfied ISP 12 −1.18 12 −1.38
Somewhat satisfied ISP 7 −0.15 6 −0.38

BM Bowel movement, CS Carcinoid syndrome, ISP Interview subpopulation, ITT Intent-to-treat, SES Standardized effect size

aThere were n = 75 “not changed to yes at Week 12”

bThere were n = 10 “a little better”; n = 10 “the same”; and n = 1 “a little worse”

cThere were n = 8 “neither satisfied nor dissatisfied”; n = 3 “somewhat dissatisfied”; and n = 3 “very satisfied”